-
EP2037922
European procedure
Extract from the Register of European Patents
EP About this file: EP2037922
| EP2037922 - PROLYL HYDROXYLASE INHIBITORS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 28.11.2014 Database last updated on 01.04.2026 | Most recent event Tooltip | 21.07.2017 | Correction of patent specification | published on 23.08.2017 [2017/34] | Applicant(s) | For all designated states GlaxoSmithKline LLC Corporation Service Company 2711 Centreville Road Suite 400 Wilmington, Delaware 19808 / US | [2014/03] |
| Former [2010/09] | For all designated states GlaxoSmithKline LLC One Franklin Plaza 200 North 16th Street Philadelphia, PA 19102 / US | ||
| Former [2009/13] | For all designated states SmithKline Beecham Corporation One Franklin Plaza P.O. Box 7929 Philadelphia, PA 19101 / US | Inventor(s) | 01 /
DUFFY, Kevin, J. 1250 South Collegeville Road Collegeville, PA 19426 / US | 02 /
FITCH, Duke, M. 1250 South Collegeville Road Collegeville, PA 19426 / US | 03 /
JIN, Jian 1250 South Collegeville Road Collegeville, PA 19426 / US | 04 /
LIU, Ronggang 709 Swedeland Road King of Prussia, PA 19406 / US | 05 /
SHAW, Antony, N. 1250 South Collegeville Road Collegeville, PA 19426 / US | 06 /
WIGGALL, Kenneth 1250 South Collegeville Road Collegeville, PA 19426 / US | [2009/13] | Representative(s) | Sewell, Richard Charles GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | [N/P] |
| Former [2014/04] | Sewell, Richard Charles GlaxoSmithKline Corporate Intellectual Property CN925.1 980 Great West Road Brentford, Middlesex TW8 9GS / GB | ||
| Former [2009/13] | Sewell, Richard Charles GlaxoSmithKline (CN925.1), 980 Great West Road Brentford Middlesex TW8 9GS / GB | Application number, filing date | 07798915.0 | 22.06.2007 | [2009/13] | WO2007US71854 | Priority number, date | US20060805602P | 23.06.2006 Original published format: US 805602 P | [2009/13] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2007150011 | Date: | 27.12.2007 | Language: | EN | [2007/52] | Type: | A2 Application without search report | No.: | EP2037922 | Date: | 25.03.2009 | Language: | EN | The application published by WIPO in one of the EPO official languages on 27.12.2007 takes the place of the publication of the European patent application. | [2009/13] | Type: | B1 Patent specification | No.: | EP2037922 | Date: | 22.01.2014 | Language: | EN | [2014/04] | Type: | B9 Corrected patent specification | No.: | EP2037922 | Date: | 23.08.2017 | [2017/34] | Search report(s) | International search report - published on: | US | 27.03.2008 | (Supplementary) European search report - dispatched on: | EP | 20.07.2012 | Classification | IPC: | A61K31/47, A61K31/495, C07D487/08, A61K31/513, A61K31/5377, A61P7/06 | [2012/34] | CPC: |
C07D239/60 (EP,NO,US);
C07D239/22 (EP,NO,US);
C07D487/08 (KR);
A61K31/47 (KR);
A61K31/495 (KR);
A61K31/515 (EP,NO,US);
A61P43/00 (EP);
A61P7/00 (EP);
A61P7/06 (EP);
A61P9/00 (EP);
A61P9/10 (EP);
C07D239/54 (EP,NO,US);
C07D239/62 (EP,US);
C07D401/04 (EP,NO,US);
C07D405/04 (EP,NO,US);
C07D405/10 (EP,NO,US);
C07D409/04 (EP,NO,US);
C07D409/10 (EP,NO,US);
|
| Former IPC [2009/13] | A61K31/47, A61K31/495, C07D487/08 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2009/13] | Extension states | HR | 16.01.2009 | Title | German: | PROLYL-HYDROXYLASE-HEMMER | [2009/13] | English: | PROLYL HYDROXYLASE INHIBITORS | [2009/13] | French: | INHIBITEURS DE PROLYLE HYDROXYLASE | [2009/13] | Entry into regional phase | 16.01.2009 | National basic fee paid | 16.01.2009 | Search fee paid | 16.01.2009 | Designation fee(s) paid | 16.01.2009 | Examination fee paid | Examination procedure | 16.01.2009 | Amendment by applicant (claims and/or description) | 16.01.2009 | Examination requested [2009/13] | 07.03.2013 | Communication of intention to grant the patent | 01.07.2013 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 30.08.2013 | Communication of intention to grant the patent | 10.12.2013 | Fee for grant paid | 10.12.2013 | Fee for publishing/printing paid | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 07.03.2013 | Opposition(s) | 23.10.2014 | No opposition filed within time limit [2015/01] | Fees paid | Renewal fee | 05.06.2009 | Renewal fee patent year 03 | 31.03.2010 | Renewal fee patent year 04 | 07.06.2011 | Renewal fee patent year 05 | 31.03.2012 | Renewal fee patent year 06 | 31.03.2013 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A] WO03049686 (FIBROGEN INC et al.) [A] 1-17 * Quinolyl and isoquinolyl carbonyl glycine derivatives.; paragraph [0032] - paragraph [0034]; claim 3 * | [A] WO2004108681 (FIBROGEN INC et al.) [A] 1-17 * paragraph [0045]; claims 37,38 * | [E] WO2008089051 (SMITHKLINE BEECHAM CORP et al.) [E] 1-17 * the whole document * | International search | [Y] US5658933 (WEIDMANN KLAUS et al.) [Y] | [Y] MCDONOUGH M.A. ET AL: "Cellular Oxygen Sensing: Crystal Structure of Hypoxia-Inducible Factor Prolyl hydroxylase (PHD2)", PNAS, vol. 103, no. 26, 16 June 2006 (2006-06-16), pages 9814 - 9819, XP002432975 [Y] DOI: http://dx.doi.org/10.1073/pnas.0601283103 | [Y] SILVERBERG ET AL.: "The Use of Subcutaneous Erythropoietin and Intravenous Iron for the Treatment of the Anemia for Severe Resistant, Congestive Heart Failure, Improves Cardiac and Renal Function and Functional Cardiac Class and Markedly Reduces Hospitalizations", JOURNAL OF AMERICAN COLLEGE OF CARDIOLOGY, vol. 35, June 2000 (2000-06-01), pages 1737 - 1744, XP002212471 [Y] DOI: http://dx.doi.org/10.1016/S0735-1097(00)00613-6 |